These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32573602)

  • 1. High-throughput single-cell analysis of exosome mediated dual drug delivery, in vivo fate and synergistic tumor therapy.
    Wang J; Li G; Tu C; Chen X; Yang B; Huo Y; Li Y; Chen AZ; Lan P; Zhang YS; Xie M
    Nanoscale; 2020 Jul; 12(25):13742-13756. PubMed ID: 32573602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loading of metal isotope-containing intercalators for mass cytometry-based high-throughput quantitation of exosome uptake at the single-cell level.
    Wang J; Tu C; Zhang H; Zhang J; Feng Y; Deng Y; Huo Y; Xie M; Yang B; Zhou M; Liu J
    Biomaterials; 2020 Oct; 255():120152. PubMed ID: 32505035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate.
    Shao J; Zaro J; Shen Y
    Int J Nanomedicine; 2020; 15():9355-9371. PubMed ID: 33262592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents.
    Lin Y; Lu Y; Li X
    J Drug Target; 2020 Feb; 28(2):129-141. PubMed ID: 31280623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
    Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S
    Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
    Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
    Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome engineering in cell therapy and drug delivery.
    Sadeghi S; Tehrani FR; Tahmasebi S; Shafiee A; Hashemi SM
    Inflammopharmacology; 2023 Feb; 31(1):145-169. PubMed ID: 36609717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionalized exosome harboring bioactive molecules for cancer therapy.
    Kim YK; Choi Y; Nam GH; Kim IS
    Cancer Lett; 2020 Oct; 489():155-162. PubMed ID: 32623071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes as a Drug Delivery System in Cancer Therapy: Potential and Challenges.
    Kibria G; Ramos EK; Wan Y; Gius DR; Liu H
    Mol Pharm; 2018 Sep; 15(9):3625-3633. PubMed ID: 29771531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New advances in exosome-based targeted drug delivery systems.
    Ferreira D; Moreira JN; Rodrigues LR
    Crit Rev Oncol Hematol; 2022 Apr; 172():103628. PubMed ID: 35189326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome-based Tumor Therapy: Opportunities and Challenges.
    Li C; Hou X; Zhang P; Li J; Liu X; Wang Y; Guan Q; Zhou Y
    Curr Drug Metab; 2020; 21(5):339-351. PubMed ID: 32410558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium.
    Wan Z; Zhao L; Lu F; Gao X; Dong Y; Zhao Y; Wei M; Yang G; Xing C; Liu L
    Theranostics; 2020; 10(1):218-230. PubMed ID: 31903116
    [No Abstract]   [Full Text] [Related]  

  • 15. Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations.
    Kim MS; Haney MJ; Zhao Y; Yuan D; Deygen I; Klyachko NL; Kabanov AV; Batrakova EV
    Nanomedicine; 2018 Jan; 14(1):195-204. PubMed ID: 28982587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of Exosomes-An Important Factor for Elucidating the Biological Roles of Exosomes and for the Development of Exosome-Based Therapeutics.
    Morishita M; Takahashi Y; Nishikawa M; Takakura Y
    J Pharm Sci; 2017 Sep; 106(9):2265-2269. PubMed ID: 28283433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy.
    Yang L; Han D; Zhan Q; Li X; Shan P; Hu Y; Ding H; Wang Y; Zhang L; Zhang Y; Xue S; Zhao J; Hou X; Wang Y; Li P; Yuan X; Qi H
    Theranostics; 2019; 9(25):7680-7696. PubMed ID: 31695794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery.
    Jang H; Kim H; Kim EH; Han G; Jang Y; Kim Y; Lee JW; Shin SC; Kim EE; Kim SH; Yang Y
    Biomater Res; 2023 Nov; 27(1):124. PubMed ID: 38031117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post isolation modification of exosomes for nanomedicine applications.
    Hood JL
    Nanomedicine (Lond); 2016 Jul; 11(13):1745-56. PubMed ID: 27348448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA.
    Lu M; Zhao X; Xing H; Xun Z; Zhu S; Lang L; Yang T; Cai C; Wang D; Ding P
    Int J Pharm; 2018 Oct; 550(1-2):100-113. PubMed ID: 30138707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.